Search Share Prices
GSK Headlines - GlaxoSmithKline (LON:GSK) Given Buy Rating at Jefferies Financial Group
GlaxoSmithKline (LON:GSK)‘s stock had its “buy” rating reiterated by equities research analysts at Jefferies Financial Group in a note issued to investors on Tuesday, Analyst Ratings Network reports.
GlaxoSmithKline (LON:GSK) Price Target Cut to GBX 1,300 by Analysts at JPMorgan Chase & Co.
GlaxoSmithKline (LON:GSK) had its price target trimmed by JPMorgan Chase & Co. from GBX 1,500 ($19.60) to GBX 1,300 ($16.98) in a research report sent to investors on Tuesday, Price Targets.com ...
GlaxoSmithKline (LON:GSK) Given a GBX 1,300 Price Target at JPMorgan Chase & Co.
GlaxoSmithKline (LON:GSK) has been given a GBX 1,300 ($16.98) price objective by investment analysts at JPMorgan Chase & Co. in a note issued to investors on Tuesday, Borsen Zeitung reports. The firm ...
GlaxoSmithKline (LON:GSK) Given a GBX 1,450 Price Target by UBS Group Analysts
UBS Group set a GBX 1,450 ($18.94) target price on GlaxoSmithKline (LON:GSK) in a report published on Thursday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock. Several ...
GlaxoSmithKline downgraded to ‘sell’ by Deutsche Bank after results worse than expected
GlaxoSmithKline PLC was downgraded to ‘sell’ from ‘hold’ by Deutsche Bank following a set of disappointing results that present an even more challenging outlook than expec ...